Author

Daniel Centeno

Stevens Institute of TechnologyPrimary ORCID profile (0009-0004-9984-623X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Daniel CentenoiD1 paper · Stevens Institute of Technology

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Cezary MiedziarekiD· 1 shared Elżbieta Dziabaszewska· 1 shared Jan Savas-Carstens· 1 shared Laura A. MartiniD· 1 shared Marcin IwanickiiD· 1 shared Mikołaj Piotr ZaborowskiiD· 1 shared Pek Yee LumiD· 1 shared Piotr JasińskiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Cezary MiedziarekORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Suppression of Ovarian Cancer Cell Proliferation is Associated with Upregulation of Cell-Matrix Adhesion Programs and Integrin-β4-Induced Cell Protection from Cisplatin.

Sadaf Farsinejad, Daniel Centeno, Jan Savas-Carstens, Teagan Polotaye, Tonja Pavlovič, Pouria Babvey, Taru E. Muranen, Cezary Miedziarek, Piotr Jasiński, Elżbieta Dziabaszewska, Mikołaj Piotr Zaborowski, Pek Yee Lum, Laura A. Martin, Marcin Iwanicki

This study shows that integrin-β4 upregulation suppresses ovarian cancer cell proliferation and protects cells from cisplatin, suggesting a role in chemoresistance.

Cancers · Apr 27, 2025Peer-reviewedCancer Biology